Genetic and molecular risk factors within the newly identified primate-specific exon of the SAP97/DLG1 gene in the 3q29 schizophrenia-associated locus. Uezato A, Yamamoto N, Jitoku D, Haramo E, Hiraaki E, Iwayama Y, Toyota T, Umino M, Umino A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, KurumajiA, Yoshikawa T, Nishikawa T. Am J Med Genet B Neuropsychiatr Genet. 2017Dec;174(8):798-807. doi: 10.1002/ajmg.b.32595. ［※LINK］
Increased subjective distaste and altered insula activity to umami tastant in patients with bulimia nervosa. Setsu R, Hirano Y, Tokunaga M, Takahashi T, Numata N, Matsumoto K, Masuda Y, Matsuzawa D, Iyo M, Shimizu E, Nakazato M. Frontiers in Psychiatry、2017Sep 25;8:172. doi: 10.3389/fpsyt.2017.00172. eCollection 2017. ［※LINK］
Group cognitive remediation therapy for younger adolescents with anorexia nervosa: a feasibility study in a Japanese sample. Kuge R, Lang K, Yokota A, Kodama S, Morino Y, Nakazato M, Shimizu E. BMC Res Notes. 2017 Jul 25;10(1):317. doi: 10.1186/s13104-017-2642-5. ［※LINK］
Feasibility of Cognitive remediation therapy for adults with autism spectrum disorders: a single-group pilot study. Okuda T, Asano K, Numata N, Hirano Y, Yamamoto T, Tanaka M, Matsuzawa D, Shimizu E, Iyo M, Nakazato M. Neuropsychiatric Disease and Treatment, 2017:13, 2185--2191. ［※LINK］
A feasibility study of the clinical effectiveness and cost-effectiveness of individual cognitive behavioral therapy for panic disorder in a Japanese clinical setting: an uncontrolled pilot study. Seki Y, Nagata S, Shibuya T, Yoshinaga N, Yokoo M, Ibuki H, Minamitani N, Kusunoki M, Inada Y, Kawasoe N, Adachi S, Yoshimura K, Nakazato M, Iyo M, Nakagawa A, Shimizu E.
BMC Res Notes. 2017 Feb 6;10(1):86. doi: 10.1186/s13104-017-2398-y. ［※LINK］
Altered serum level of matrix metalloproteinase-9 and its association with decision-making in eating disorders. Matsumoto J, Hirano Y, Hashimoto K, Ishima T, Kanahara N, Niitsu T, Shiina A, Hashimoto T, Sato Y, Yokote K, Murano S, Kimura H, Hosoda Y, Shimizu E, Iyo M, Nakazato M. Psychiatry Clin Neurosci. 2017 Feb;71(2):124-134. doi: 10.1111/pcn.12490. ［※LINK］
Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia. Nakata Y, Kanahara N, Kimura H, Watanabe H, Iyo M. Int Clin Psychopharmacol. 2017 May;32(3):169-173. doi: 10.1097/YIC.0000000000000160. ［※LINK］
Comprehensive association analysis of 27 genes from the GABAergic system in Japanese individuals affected with schizophrenia. Balan S, Yamada K, Iwayama Y, Hashimoto T, Toyota T, Shimamoto C, Maekawa M, Takagai S, Wakuda T, Kameno Y, Kurita D, Yamada K, Kikuchi M, Hashimoto T, Kanahara N, Yoshikawa T. Schizophr Res. 2017 Jul;185:33-40. doi: 10.1016/j.schres.2017.01.003. ［※LINK］
